Stock listing

LSE:GENI GENinCode PLC Share Price

Home listing (LSE) of GENinCode PLC

Follow GENinCode PLC into a list and get an email when it puts out news.

Share price · LSE:GENI

0.55p GBX (pence) -0.05 (-8.3%)

Close on Nov 20, 2026

Past year -76.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
0.50p – 0.60p GBX (pence)Nov 20, 2026
Volume
2.20M sharesNov 20, 2026
Market cap
£4.14M GBPAt the close on Nov 20, 2026 · price × 753.0M shares outstanding
52-week range
0.50p – 4.90p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£21,018 GBPMedian day 1.36M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
GENinCode PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:GENI · Home0.55p GBX (pence)-0.05 (-8.3%)2,203,3050.60p0.60p0.50p0.60pClose on Nov 20, 2026
Frankfurt:9PL€0.0030 EUR-0.0020 (-40.0%)——€0.0060—€0.0050Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:GENI · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
0.55p-0.05-8.3%0.60p0.60p0.50p2,203,305
0.60p0.000.0%0.60p0.60p0.55p55,528
0.60p0.000.0%0.577p0.65p0.55p81,684
0.60p0.000.0%0.65p0.65p0.56p136,022
0.60p+0.02+3.4%0.55p0.65p0.55p1,680,337
0.58p-0.02-3.3%0.65p0.65p0.55p142,203
0.60p0.000.0%0.65p0.65p0.56p368,649
0.60p0.000.0%0.63p0.65p0.55p30,706
0.60p0.000.0%0.583p0.65p0.56p2,060,524
0.60p+0.02+3.4%0.598p0.60p0.55p5,455,341
0.58p+0.03+5.5%0.58p0.619p0.50p5,033,418
0.55p-0.10-15.4%0.607p0.70p0.518p7,991,461
0.65p0.000.0%0.65p0.70p0.60p2,320,003
0.65p-0.01-1.5%0.70p0.70p0.60p296,697
0.66p0.000.0%0.65p0.70p0.621p821,230
0.66p-0.04-5.7%0.65p0.67p0.62p1,402,098
0.70p0.000.0%0.652p0.75p0.652p311,276
0.70p-0.025-3.4%0.80p0.80p0.65p5,985,976
0.725p0.000.0%0.745p0.80p0.65p1,297,669
0.725p+0.10+16.0%0.60p0.85p0.60p7,904,894
0.625p-0.025-3.8%0.65p0.65p0.60p564,504
0.65p-0.025-3.7%0.675p0.70p0.612p4,233,805
0.675p+0.075+12.5%0.60p0.70p0.575p3,865,641
0.60p-0.025-4.0%0.625p0.65p0.561p1,374,835
0.625p0.000.0%0.625p0.636p0.625p79,436
0.625p0.000.0%0.625p0.65p0.60p109,277
0.625p0.000.0%0.625p0.637p0.601p529,109
0.625p0.000.0%0.625p0.65p0.601p220,851
0.625p0.000.0%0.625p0.65p0.60p1,007,932
0.625p0.000.0%0.625p0.65p0.60p277,433
0.625p0.000.0%0.625p0.65p0.588p360,021
0.625p-0.05-7.4%0.675p0.70p0.605p2,336,078
0.675p-0.025-3.6%0.70p0.72p0.65p2,764,493
0.70p0.000.0%0.70p0.75p0.65p311,245
0.70p0.000.0%0.70p0.75p0.65p966,851
0.70p0.000.0%0.70p0.75p0.65p2,249,511
0.70p0.000.0%0.70p0.75p0.65p1,356,034
0.70p-0.175-20.0%0.80p0.80p0.636p22,954,144
0.875p0.000.0%0.875p0.899p0.854p94,424
0.875p0.000.0%0.875p0.90p0.854p718,082
0.875p0.000.0%0.875p0.90p0.85p1,801,413
0.875p0.000.0%0.875p0.90p0.85p1,359,025
0.875p0.000.0%0.875p0.90p0.854p99,515
0.875p-0.025-2.8%0.90p0.92p0.85p2,012,713
0.90p+0.05+5.9%0.85p0.95p0.80p5,287,333
0.85p+0.025+3.0%0.825p0.85p0.80p1,012,902
0.825p-0.025-2.9%0.85p0.85p0.80p999,259
0.85p0.000.0%0.85p0.90p0.80p3,569,064
0.85p0.000.0%0.85p0.90p0.80p4,093,902
0.85p-0.10-10.5%0.95p0.97p0.813p5,699,294
0.95p0.000.0%0.95p1.00p0.90p2,733,624
0.95p0.000.0%0.95p1.00p0.90p4,532,754
0.95p0.000.0%0.95p1.00p0.90p391,667
0.95p-0.075-7.3%1.025p1.10p0.90p2,894,231
1.025p+0.075+7.9%0.95p1.10p0.90p3,273,306
0.95p-0.025-2.6%0.975p1.00p0.90p943,134
0.975p-0.025-2.5%1.00p1.05p0.95p583,564
1.00p-0.05-4.8%1.05p1.10p0.95p3,756,693
1.05p+0.10+10.5%1.025p1.25p0.95p21,428,256
0.95p+0.075+8.6%0.875p0.98p0.825p5,708,782
0.875p-0.025-2.8%0.875p0.899p0.852p329,414
0.90p+0.025+2.9%0.875p0.90p0.85p3,578,240
0.875p0.000.0%0.875p0.90p0.85p1,150,041
0.875p0.000.0%0.875p0.90p0.856p2,102,440
0.875p-0.025-2.8%0.891p0.891p0.85p987,749
Ticker
LSE:GENI
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LSE
Currency
GBX

What changed lately

Calls

Replays

  • GENinCode (LSE:GENI) — Full year results briefing

    Wed, Jun 10, 2026 · 6:00 AM ET

    Watch Transcript
  • GENinCode (LSE:GENI) — Interim results presentation

    Thu, Oct 02, 2025 · 6:00 AM ET

    Watch Transcript
  • GENinCode (LSE:GENI) — Full year results briefing

    Thu, Jun 05, 2025 · 9:00 AM ET

    Watch Transcript

Latest news

Holding(s) in Company

Nov 6, 2026

Closed 0.60p (+3.4%) on Nov 6, 2026

Half-year Financial Report

Sep 29, 2026

Closed 0.70p (-20.0%) on Sep 29, 2026

Additional Subscription

Feb 6, 2026

Closed 1.15p (0.0%) on Feb 6, 2026

Result of Retail Offer

Jan 26, 2026

Closed 1.05p (-4.5%) on Jan 26, 2026

Result of Placing and Subscription

Jan 22, 2026

Closed 1.15p (-37.8%) on Jan 22, 2026

Retail Offer

Jan 21, 2026

Closed 1.15p (-37.8%) on Jan 22, 2026

Placing and Subscription

Jan 21, 2026

Closed 1.15p (-37.8%) on Jan 22, 2026

Collaboration with Sohin Genetics

Dec 17, 2025

Closed 2.80p (-1.8%) on Dec 17, 2025

All GENinCode PLC news

Financings

  • Private placement of new Ordinary Shares (Additional Subscription Shares)

    Feb 6, 2026 · US$789,256

    Announced: £580,000 · GBX 1 a share

    Use of proceeds: Additional funding and a longer cash runway while providing the FDA with updates for the De Novo application for its CARDIO inCode-Score test

    Announced Feb 6, 2026

  • New Ordinary Shares (WRAP Retail Offer)

    Jan 26, 2026 · US$273,712

    Closed: £200,000 raised · GBX 1 a share · Winterflood Securities Limited

    Dealers: Winterflood Securities Limited

    Announced Jan 21, 2026 · Update Jan 21, 2026 · Closed Jan 26, 2026

  • Private placement of new ordinary shares (Placing Shares)

    Jan 21, 2026 · US$3.49M

    Announced: £2.6M · GBX 1 a share · Cavendish Capital Markets Limited +2

    Dealers: Cavendish Capital Markets Limited (co-lead), Oberon Capital (co-lead), Turner Pope Investments (TPI) Ltd (co-lead)

    Use of proceeds: US commercialisation and scale-up, EU and UK expansion, fundraising costs and general working capital

    Announced Jan 21, 2026

  • Private placement of new ordinary shares (Subscription Shares)

    Jan 21, 2026 · US$1.21M

    Announced: £900,000 · GBX 1 a share

    Buyers: Nestor Oller (entities associated with existing shareholder Nestor Oller, with certain Directors, to subscribe for 87,300,000 Subscription Shares raising £0.9 million in aggregate)

    Insiders: Certain Directors intend to subscribe alongside entities associated with Nestor Oller

    Announced Jan 21, 2026

  • Private placement of new ordinary shares

    Mar 3, 2025

    Update: Cavendish Capital Markets Limited +1

    Dealers: Cavendish Capital Markets Limited (co-lead), Oberon Capital (co-lead)

    Buyers: Santi-1990 SL (Nestor Oller) (9,459,460 shares)

    Update Mar 3, 2025

Read by 6ix AI from the company's releases

GENinCode PLC on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
14 in the last 12 months · 68 in all · newest Nov 6, 2026 · oldest 2021
Calls
10 calls with a replay · 10 with a transcript · latest Jun 10, 2026

Where GENinCode PLC is listed

ListingExchangeCountryCurrency
LSE:GENI · Home listing · This pageLSEUnited KingdomGBX
LS Exchange:A3C31YLS ExchangeGermanyEUR
Lang & Schwarz:A3C31YLang & SchwarzGermanyEUR
Frankfurt:9PLFrankfurtGermanyEUR
Stuttgart:9PLStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about GENinCode PLC.